Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
#4222 Quali-NET: A prospective study on patient-reported quality of life in neuroendocrine neoplasms
Introduction: Neuroendocrine neoplasms of the lung (LNEN) or gastro-enteropancreatic tract (GEPNEN) are typically slow-growing, leading to longer overall survival, and resembling chronic illnesses. Therefore, focus on quality of life (QoL) is crucial. While brief studies have been done, comprehensive, long-term studies are needed.
Conference:
Presenting Author: Islam O
Authors: Islam O, Depauw L, van der Massen I, Simoens M, Galdermans D,
Keywords: GEP-NEN, LNEN, Quality of life, Longitudinal data,
Introduction: Neuroendocrine neoplasms (NENs) are associated with poor health-related quality of life (HRQOL) due to tumor and hormonal related symptoms and treatment-related toxicity. Peptide receptor radionuclide therapy (PRRT) delivers targeted therapy for tumor and hormonal control.
Conference:
Presenting Author: Cehic G
Authors: Cehic G, Kong G, Corsini N, Chan D, Pavlakis N,
Introduction: Retrospective data for peptide receptor radionuclide therapy (PRRT) have demonstrated promising activity in somatostatin receptor (SSTR)-positive lung neuroendocrine tumors (NETs).
Conference:
Presenting Author:
Authors: García-Álvarez A, Garcia-Carbonero R, Anido U, Jimenez-Fonseca P, Del Olmo-García M,
Keywords: Lung NET, Peptide receptor radionuclide therapy,
Introduction: The somatostatin analogue LAN is a common first-line treatment for NETs that can be given at home in a ready-to-use syringe every 4 weeks in the UK.
Conference:
Presenting Author: Khan M
Authors: Khan M, Davies L, Back M, Shah T, Pritchard D,
Keywords: patient participation, somatostatin analogues, injections, quality of life, value-based health care,